| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5695042 | Fertility and Sterility | 2017 | 6 Pages |
Abstract
Our findings indicate that in young women with PCOS, low AMH levels predict a greater risk of MetSyn. The role of AMH, an established biomarker of ovarian reserve, in risk stratification of cardiometabolic risk in obese women with PCOS needs to be clarified in longitudinal studies and in the perimenopausal population.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Rebecca A. M.D., Kathleen M.D., Samantha F. M.D., M.S.C.E., Anuja M.D., Ph.D.,